Please make JavaScript on and see this site.

Font size

Pmda - Pharmaceuticals and Medical Devices Agency

Menu

Close

Safety Alert & Recalls/ Review Reports/ Package Inserts etc.

Formats DL

About PMDA

About PMDA

Formats DL

Safety Alert & Recalls/ Review Reports/ Package Inserts etc.

Back

Back

For Regulatory Authorities
Regulations & Services of PMDA
Information about Approved Products in Japan
Safety Information
Advanced Efforts
FAQ
- Frequently Asked Questions (FAQ)
For Healthcare Professionals
Information for approved products in Japan
Safety information
FAQ
- Frequently Asked Questions (FAQ)
For Academia
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
- The Science Board
FAQ
- Frequently Asked Questions (FAQ)
For Business
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
- Master File System
- Accreditation of Foreign Manufacturers
Advanced efforts
FAQ
- Frequently Asked Questions (FAQ)

Back

Drugs
Regulations and Services of PMDA
Information for apporoved products in Japan
- New drugs
Safety information
Procedures in Japan
- Master File System
- Accreditation of Foreign Manufacturers
Advanced efforts
Medical devices
Regulations and Services of PMDA
Information for apporoved products in Japan
- New devices
Safety information
- PMDA Medical Safety Information
Procedures in Japan
- Accreditation of Foreign Manufacturers
Advanced efforts
Quasi-drugs
Reviews and Related Services
Regulatory Procedures
- Accreditation of Foreign Manufacturers
Post-marketing Safety Measures
- Outline of Post-marketing Safety Measures
Regenerative medical products
Reviews and Related Services
Post-marketing Safety Measures
- Outline of Post-marketing Safety Measures
Advanced Efforts
- CPC (Cell Processing Center) Subcommittee
- Cellular and Tissue-based Products Subcommittee

Home
Regulatory Science/The Science Board/Standard Development
Regulatory Science Coordination
Measures for advanced science and technology
Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
The 6th Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

Regulatory Science/The Science Board/Standard Development

The 6th Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

日本語ページはこちら

Press Release

September 22, 2022 from 2pm to 4pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

Agenda

Final Draft of the Report on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes to Members
Others

List of Handouts

Document 1 Summary of Discussions at the 4th Working Group
Document 2 Draft Report (Integrated Version)

Minutes

Minutes of the 6th Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes (in Japanese)【PDF:270KB】